Charged by Surgical Robot’s Approval, Shenzhen Edge Medical Makes New IPO Bid

The medical device maker filed a second time for a Hong Kong IPO after updating its prospectus with the recent approval of its first surgical robot Key Takeaways: By Ellie Si Shenzhen Edge Medical Co. Ltd. hopes the second try will be the charm for its bid to list in Hong Kong, this time armed with a major new product approval. Eight months after its first IPO attempt, the surgical robot maker filed an updated prospectus last week revealing the regulatory nod for a key product that will bring the…

Read More »

Medical Device Maker Broncus Gets Financial Breathing Room from IPO

Company’s shares plunge 20% on first trading day, but rebound slightly the next day, following listing that raised $200 million Key Takeaways: Broncus Holding has raised $200 million from its Hong Kong IPO, giving it enough cash to fund its operations into early 2023 Investors are betting company can quickly ramp up sales for its core pulmonary devices, most of which have been approved or are near approval in China, the U.S. and Europe By Doug Young Seven months. That’s how much time medical device maker Broncus Holding Corp. (2216.HK)…

Read More »